Rituximab

Strength: 100 mg, 500 mg

Dosage Form: Injection solution

Description:

Rituximab is a monoclonal antibody targeting CD20 on B-cells, used in non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and autoimmune disorders.

Key Features:

• Targets malignant and normal B-cells
• Can be combined with chemotherapy
• IV infusion administration

Precautions:

Risk of infusion-related reactions and infections. Monitor for progressive multifocal leukoencephalopathy (PML).